Europe Leukapheresis Market

Market Introduction

The Europe Leukapheresis market is analyzed based on three large countries: Germany, the UK, France, Italy, Spain, and RoE. Germany is contributing a major share in the growth of leukapheresis market. Germany is an attractive market due to its steady growth and innovative approach to healthcare. According to the Federal Statistical Office, health expenditure in Germany in 2019 amounted to US$ 460.03 billion. The German medical device market is one of the largest in Europe and the third-largest in the world. The demand for highly innovative technologies and diagnostic, therapeutic, and minimally invasive devices remains high worldwide. Germany's medical device manufacturers can also apply for state funding for various research projects and receive grants from the Reconstruction Loan Corporation (KfW). Manufacturers' increasing focus on new product development and strategic collaborations to develop advanced diagnostic devices like leukapheresis is expected to fuel market growth. Germany has a strong health system, especially infrastructure, hospital beds, and trained staff. In 2018, according to the Ministry of Health, there were almost 498,400 beds in 1,925 hospitals, 1,142 rehabilitation centers, and 19,075 pharmacies. A well-developed infrastructure makes the health industry, with 5.6 million employees, the largest employer in Germany. In 2016, around 13,900 people in Germany contracted leukemia, 4% of them under 15. The risk decreases during the transition into young adulthood but increases again from the age of 30. These incidences are higher in men than in women. One in 67 men and one in 87 women will develop leukemia at some point in their lives.

The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Russia, Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain and Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is driving the growth of the market.

Market Overview and Dynamics

The leukapheresis market in Europe is expected to grow from US$ 22.55 million in 2021 to US$ 39.26 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028. Therapeutic apheresis refers to an extracorporeal treatment that involves the selective removal of cells or other targeted abnormal substances from blood circulation. The technique has lately been explored for the treatment of various medical conditions. Extracorporeal photopheresis (ECP) is a process that is used in the treatment of lymphoma. In this process, white blood cells (WBCs) are collected from the bloodstream, treated with light-activated drugs, and exposed to UV lights, followed by infusing it back to the patient body. Therapeutic plasma exchange is a potential method employed to treat medical conditions such as multiple sclerosis, myeloma, and leukemia. The technique withdraws plasma from the patient’s blood and replaces it with fresh donor plasma or bottled human albumin solution. Further, the double filtration plasmapheresis technique is used for rapidly progressive glomerulonephritis and low-density lipoprotein (LDL) apheresis or leukocytapheresis for the nephritic syndrome. These techniques are two major apheresis therapies that are used to treat kidney diseases. Thus, the widening scope of apheresis technology in therapeutics is emerging as a prevalent trend in the leukapheresis market.

Key Market Segments

In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021.  Based on end user, blood component providers and blood centers segment held the largest share in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; STEMEXPRESS; and BioIVT among others.

Reasons to buy report

• To understand the Europe leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe leukapheresis market
• Efficiently plan M&A and partnership deals in Europe leukapheresis market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe leukapheresis market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Leukapheresis Market Segmentation

Europe Leukapheresis Market – By Product Type

• Leukapheresis Disposables
• Leukapheresis Devices

Europe Leukapheresis Market – By Application

• Research Applications
• Therapeutic Applications

Europe Leukapheresis Market – By Product Type

• Blood Component Providers and Blood Centers
• Hospitals and Transfusion Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes

Europe Leukapheresis Market – By Country

• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Europe Leukapheresis Market – Companies Mentioned

• Asahi Kasei Corporation                                 
• Fresenius SE & Co. KGaA                                
• Haemonetics Corporation                              
• Terumo Corporation                                        
• STEMCELL Technologies Inc.                          
• HemaCare  
• Macopharma
• AllCells
• STEMEXPRESS  
• BioIVT                            

Europe Leukapheresis Market Strategic Insights

Europe Leukapheresis Market Report Highlights

Europe Leukapheresis Market Country and Regional Insights